$129.12 +0.30 (0.23%) Alnylam Pharmaceuticals Inc - NASDAQ

Jul. 28, 2015 | 10:59 AM
Key Statistics
Last Trade: 129.12
Trade Time: Jul 28 10:59 AM Eastern Daylight Time
Change: +0.30 (0.23%)
Prev Close: 128.82
Open: 130.20
Bid: 129.00
Ask: 129.28

Competitors

Ticker Name Volume % Change
TEVA Teva Pharma Ind Shs Sponsored American Deposit Receipt Repr 1 Sh 39.49M +16.41%
MYL Mylan N.V. 34.53M -14.51%
PFE Pfizer Inc 31.28M +0.23%
MRK Merck & Co Inc 14.85M -0.73%
XOMA Xoma Corp 13.79M -12.53%

ALNY Stock Analysis

  1. No results found.

Partner Headlines

  1. 5 Biotech Stocks On Deck With The FDA

    Benzinga | Jun. 30, 2015 | 13:39PM EST
  2. Julian Robertson Adds 16 New Stakes to Portfolio

    GuruFocus | Jun. 23, 2015 | 18:39PM EST
  3. Gurus Purchase Tekmira Pharmaceuticals in Q1

    GuruFocus | Jun. 19, 2015 | 17:57PM EST
  4. JMP Sees A 'Negative Market Tone' In Biotechnology

    Benzinga | Jun. 15, 2015 | 13:31PM EST
  5. Alnylam Reports Data on Potential Alexion Rival Drug

    IBD | Jun. 12, 2015 | 12:38PM EST
  6. US Stock Futures Slide Ahead Of Economic Data

    Benzinga | Jun. 12, 2015 | 07:22AM EST
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!